19937 results for «»
19937 results
Is only fixing functional mitral regurgitation in heart failure patients enough?
20 Nov 2023 – From PCR London Valves 2023
This session offers insights into combo therapy involving Carillon for patients with functional mitral regurgitation. It covers details of the EMPOWER trial, a double-blinded, sham-controlled study, and explores the potential benefits of early treatment for patients with functional mitral regurgitation.
A new angiographic tool to evaluate stent expansion besides intracoronary imaging
24 Nov 2023
A 57-year-old man with hypertension and dyslipidemia as cardiovascular risk factors was admitted for stable angina for months. His symptoms were not controlled despite maximal medical treatment (beta-blockers, nitrates, aspirin, statins). Angios revealed multivessel disease. How would you manage this case?

Author
Essentials of lifetime management of TAVI patients
20 Nov 2023 – From PCR London Valves 2023
In this session, discover the key features and benefits of next-generation transcatheter heart valve technology. Gain insights into managing bicuspid and valve-in-valve interventions, and understand the procedural and clinical significance of intermediate and XL sizes in addressing unmet clinical needs.
Expert roundtable: 4D ICE in tricuspid interventions
20 Nov 2023 – From PCR London Valves 2023
Join this session if you want to get familiar with the 4D ICE technology and the key elements of image guidance for tricuspid interventions, understand how 4D ICE can assist in specific procedural steps during challenging tricuspid interventions, and engage in an interactive discussion with experts...
Advancing valve repair: mastering diverse mitral and tricuspid regurgitation anatomies with the PASCAL Precision system
20 Nov 2023 – From PCR London Valves 2023
Participate in this session to stay informed about the latest clinical and real-world evidence for mitral and tricuspid TEER using PASCAL. Explore case-based discussions on mitral regurgitation treatment using PASCAL Precision, and actively participate in an educational tricuspid TEER recorded case procedure featuring the PASCAL Precision.
Enjoy new step-by-step and hands-on training at #PCRLV 2022!
PCR Tricuspid Focus Group – Referral meeting calendar
12 Oct 2023
Discover what took place during previous referral meetings, and prepare yourself for future ones!
Since 2023, the PCR Tricuspid Focus Group has been dedicated to raising awareness about tricuspid valve disease among healthcare professionals and has endorsed a total of 25 local referral meetings to date.
A referral...
PCR London Valves 2023 - Training Village Programme
- Updated in real time, Programme times shown are London time (GMT).
Promising Safety and Efficacy Results for Supraflex Cruz in HBR Subset Analysis from FIRE Trial, with 1-Month DAPT
03 Nov 2023
Dive into the PCR Imaging Valves Madrid 2024 Workshop Programme!
The unimaginable evolution of interventional cardiology from imagination to imaging
07 Nov 2023
Faith is to believe what you do not see; the reward of this faith is to see what you believe... Read this editorial by Flavio Ribichini, Martine Gilard and Salvatore Brugaletta which introduces this section dedicated to cardiovascular imaging. ...
AHA 2023: get the interventional cardiology perspective!
11 Nov 2023
Stay up to date with what is new and hot in interventional cardiology at #AHA23 in Philadelphia.
ORBITA-2 - Percutaneous coronary intervention for stable angina: A randomized, placebo-controlled trial
12 Nov 2023
Luis Ortega Paz interviews Rasha Al-Lamee and Christopher Rajkumar on the results of ORBITA-2 randomized placebo-controlled trial, which were presented at the AHA 2023 Congress in Philadelphia.

Author

Author

Author
Dapagliflozin in acute myocardial infarction: Cardiometabolic benefits without impact on cardiovascular death or heart failure hospitalization: The jury is still out
14 Nov 2023
Luis Ortega Paz provides his take on DAPA-MI - A registry-based randomized trial of dapagliflozin in patient with acute myocardial infarction without diabetes, which was presented by Stefan James at AHA 2023 in Philadelphia.

Author
Half-dose tenecteplase or primary PCI in older patients with ST-elevation myocardial infarction: The STREAM-2 1-year mortality follow-up results
15 Nov 2023
Aaysha Cader interviews Peter Sinnaeve on the STREAM-2 1-year mortality follow-up results, which were presented at the AHA 2023 Congress in Philadelphia.
Results suggest that a pharmaco-invasive strategy provides an alternative for older STEMI patients unable to undergo primary PCI.

Author

Author
Peter Sinnaeve
Leuven, Belgium

INDUSTRY PARTNERS HELPED MAKE IT HAPPEN!
Dominic Allocco
Edina, United States of America
Srinivas B C
BANGALORE, India
Mei Chau
New York, United States of America